News

Filter

Current filters:

None

251 to 260 of 97252 results

Russia may face a shortage of drugs against HIV

Russia may face a shortage of drugs against HIV

02-12-2014

Russia may face a shortage of drugs against HIV, due to disruptions of state auctions for the public…

Anti-viralsHealthPharmaceuticalProductionRussia

Merck Ebola vaccine is well-tolerated by volunteers in early trials

Merck Ebola vaccine is well-tolerated by volunteers in early trials

02-12-2014

The Ebola vaccine developed by pharma giant Merck & Co and NewLink has been well-tolerated by trial volunteers…

Anti-viralsMerck & CoNewLink GeneticsPharmaceuticalResearch

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

Global chronic obstructive pulmonary disease device market could hit $34 billion by 2020

02-12-2014

The global chronic obstructive pulmonary disease and asthma devices market is expected to reach $34 billion…

Dosage formsMarkets & MarketingMedicinePharmaceuticalRespiratory and Pulmonary

Russia faces steady growth of drug prices

Russia faces steady growth of drug prices

02-12-2014

Drug prices in Russia are steadily growing, due to the deterioration of the local business environment…

PharmaceuticalPharmaceuticals policyPharmacologyPricingRussia

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

UK Prime Minister to announce £15 million dementia research fund in Autumn Statement

02-12-2014

The UK prime minister David Cameron is to announce a £15 million ($24 million) commitment to a new fund…

NeurologicalPharmaceuticalPoliticsResearchUK

Eli Lilly and AstraZeneca enrol first patient in Phase II/III Alzheimer's therapy trial

Eli Lilly and AstraZeneca enrol first patient in Phase II/III Alzheimer's therapy trial

02-12-2014

US drug major Eli Lilly and AstraZeneca have enrolled the first patient into AMARANTH, a Phase II/III…

AstraZenecaAZD3293Eli LillyNeurologicalPharmaceuticalResearch

FDA accepts NDA filing from AstraZeneca for Iressa

FDA accepts NDA filing from AstraZeneca for Iressa

02-12-2014

The US Food and Drug Administration has accepted for filing the New Drug Application from Iressa (gefitinib)…

AstraZenecaIressaOncologyPharmaceuticalRegulationUK

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

Pozen shares slide as gastric ulcer collaboration with Sanofi ends

02-12-2014

French drug major Sanofi and North Carolina-based pharma company Pozen have agreed to end their collaboration…

FranceGastro-intestinalsLicensingPA8140/PA32540PharmaceuticalPozenSanofiUSA

Exelixis’ cabozantinib fails to meet primary endpoint in Phase III prostate cancer trial

Exelixis’ cabozantinib fails to meet primary endpoint in Phase III prostate cancer trial

02-12-2014

US biotech firm Exelixis has announced top-line results from the final analysis of COMET-2, a randomized,…

cabozantinibExelixisOncologyPharmaceuticalResearchUSA

251 to 260 of 97252 results

Back to top